Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64.82 USD | +0.19% | +0.34% | +240.08% |
09/05 | MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman | RE |
06/05 | Vertex Pharmaceuticals 1Q Sales Up 13% on Cystic Fibrosis Drug | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+240.08% | 4.24B | |
+2.97% | 108B | |
+10.21% | 105B | |
+1.57% | 23.46B | |
-12.77% | 21.72B | |
-7.05% | 18.64B | |
-37.64% | 17.45B | |
-6.50% | 17.19B | |
+6.00% | 13.99B | |
+37.20% | 12.53B |
- Stock Market
- Equities
- ALPN Stock
- News Alpine Immune Sciences, Inc.
- HC Wainwright Adjusts Alpine Immune Sciences Price Target to $50 From $32, Maintains Buy Rating